The Molecular Biology Society of Japan

[3P-0567] Impaired osteoblastic differentiation of MSCs suppresses normal hematopoiesis in MDS

Yasutaka Hayashi1, 2, Kimihito Kawabata2, 3, Yosuke Tanaka2, Yasufumi Uehara4, Yo Mabuchi5, Koichi Murakami6, Shigeru Kiryu7, Yasunori Ota8, Yusuke Yoshioka9, Akira Nishiyama6, Yuya Kunisaki10, Tomofusa Fukuyama2, Susumu Goyama2, Fumio Arai10, Takahiro Ochiya9, Tomohiko Tamura6, Daichi Inoue1, Toshio Kitamura2 (1.Dept. of Hematology-Oncology, IBRI, FBRI, 2.Cellular Therapy, IMSUT, Univ. of Tokyo, 3.Hematology-Medical Oncology, Weill Cornell Medicine, 4.Dept. of Medicine and Biosystemic Science, Kyushu Univ., 5.Department of Biochemistry and Biophysics, Tokyo Medical and Dental University, 6.Dept. of Immunol., Grad. Sch. of Med., Yokohama City Univ., 7.Dept. of Radiology, Intl. Univ. of Health and Welfare Sch. of Med., 8.Dept. of Pathology, Research Hospital, The Institute of Medical Science, The University of Tokyo, 9.Dept. Mol. Cell. Med., Inst. Med. Sci, Tokyo Med. Univ., 10.Dept. of Cancer Stem Cell Research, Kyushu Univ.)

The 44th Annual Meeting of the Molecular Biology Society of Japan

[3P-0569] Distinct antitumor effects of iberdomide against Adult T-Cell Lymphoma/Leukemia (ATL) cells.

Hidekatsu Iha1, 2, Yu Wang1, Emi Ikebe1, 3, Shunsuke Shimosaki4, Yoshiyuki Tsukamoto5, Mitsuo Hori6, Shotaro Hagiwara7, Shuichi Kusano8, Masumichi Saito3, Shuji Uno9, Kenichi Minehata9, Atsushi Suzuki9, Kazuhiro Morishita4 (1.Microbiol, Oita Univ Facult Med., 2.Mol Oncol, Oita Univ Facult Med., 3.Natl Inst Infect Dis., 4.Tumor Biochem, Univ Miyazaki Facult Med., 5.Mol Pathol, Oita Univ Facult Med., 6.Hematol, Ibaraki Cntr Hosp., 7.Mito Cntr, Tsukuba Univ Facult Med., 8.Onco Virus, Kagoshima Univ Facult Med., 9.Bristol-Myers Squibb Japan)

The 44th Annual Meeting of the Molecular Biology Society of Japan

[3P-0570] The p53 target gene p53PAD5 confers stress resistance to intestinal epithelial cells

Tatsuki Yamamoto1, 2, Kiyono Aoki1, Hiroshi Takano3, Ayaka Yamamoto4, Shotaro Yamano1, Masanobu Ohshima5, Ryoji Yao3, Toshio Watanabe4, Tomoaki Tanaka2, Rieko Ohki1 (1.Lab. of Fundamental Oncology, Natl. Cancer Ctr. Res. Inst., 2.Dept. Mol. Diag., Chiba Univ. Sch. Med., 3.Dept. Cell Biol., Cancer Inst.,JFCR, 4.Grad. Sch. of Humanities & Sci., Nara Women's Univ, 5.Div. Genet., Cancer Res. Inst., Kanazawa Univ)

The 44th Annual Meeting of the Molecular Biology Society of Japan